Put Options

27 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$12.78 - $17.4 $500,976 - $682,080
39,200 Added 33.62%
155,800 $2.53 Million
Q1 2024

May 15, 2024

SELL
$10.67 - $14.43 $2.51 Million - $3.39 Million
-235,000 Reduced 66.84%
116,600 $1.65 Million
Q4 2023

Feb 14, 2024

SELL
$8.12 - $10.63 $974,399 - $1.28 Million
-120,000 Reduced 25.45%
351,600 $3.67 Million
Q3 2023

Nov 14, 2023

BUY
$7.48 - $10.7 $561,000 - $802,500
75,000 Added 18.91%
471,600 $4.81 Million
Q2 2023

Aug 14, 2023

BUY
$7.2 - $9.47 $1.09 Million - $1.44 Million
151,600 Added 61.88%
396,600 $2.99 Million
Q1 2023

May 15, 2023

SELL
$8.36 - $11.37 $7.98 Million - $10.9 Million
-955,000 Reduced 79.58%
245,000 $2.17 Million
Q4 2022

Feb 14, 2023

BUY
$7.95 - $9.48 $2.39 Million - $2.84 Million
300,000 Added 33.33%
1,200,000 $10.9 Million
Q2 2022

Aug 15, 2022

SELL
$7.38 - $10.4 $963,090 - $1.36 Million
-130,500 Reduced 12.66%
900,000 $6.77 Million
Q1 2022

May 16, 2022

SELL
$7.33 - $9.39 $986,618 - $1.26 Million
-134,600 Reduced 11.55%
1,030,500 $9.68 Million
Q4 2021

Feb 14, 2022

BUY
$7.9 - $10.19 $2.14 Million - $2.76 Million
270,500 Added 30.24%
1,165,100 $9.33 Million
Q3 2021

Nov 15, 2021

BUY
$8.38 - $10.18 $6.24 Million - $7.58 Million
744,600 Added 496.4%
894,600 $8.71 Million
Q2 2021

Aug 16, 2021

SELL
$9.9 - $11.56 $495,000 - $578,000
-50,000 Reduced 25.0%
150,000 $1.49 Million
Q1 2021

May 17, 2021

SELL
$10.34 - $12.81 $10.5 Million - $13 Million
-1,014,800 Reduced 83.54%
200,000 $2.31 Million
Q4 2020

Feb 16, 2021

SELL
$8.61 - $11.04 $2.04 Million - $2.62 Million
-236,900 Reduced 16.32%
1,214,800 $11.7 Million
Q3 2020

Nov 16, 2020

BUY
$8.57 - $12.69 $1.34 Million - $1.99 Million
156,900 Added 12.12%
1,451,700 $13.1 Million
Q2 2020

Aug 14, 2020

SELL
$8.12 - $13.12 $950,039 - $1.54 Million
-117,000 Reduced 8.29%
1,294,800 $16 Million
Q1 2020

May 15, 2020

SELL
$6.69 - $13.45 $9.47 Million - $19 Million
-1,416,100 Reduced 50.08%
1,411,800 $12.7 Million
Q4 2019

Feb 14, 2020

SELL
$6.53 - $10.72 $7.38 Million - $12.1 Million
-1,129,500 Reduced 28.54%
2,827,900 $27.7 Million
Q3 2019

Nov 14, 2019

BUY
$6.16 - $9.6 $5.79 Million - $9.02 Million
940,000 Added 31.15%
3,957,400 $27.2 Million
Q2 2019

Aug 14, 2019

BUY
$8.12 - $15.72 $16.4 Million - $31.7 Million
2,016,700 Added 201.53%
3,017,400 $27.9 Million
Q1 2019

May 15, 2019

SELL
$15.58 - $20.01 $40.1 Million - $51.6 Million
-2,576,300 Reduced 72.02%
1,000,700 $15.7 Million
Q4 2018

Feb 14, 2019

SELL
$14.59 - $23.84 $9.05 Million - $14.8 Million
-620,000 Reduced 14.77%
3,577,000 $55.2 Million
Q3 2018

Nov 14, 2018

SELL
$21.06 - $25.65 $2.11 Million - $2.57 Million
-100,000 Reduced 2.33%
4,197,000 $90.4 Million
Q2 2018

Aug 14, 2018

SELL
$16.77 - $24.71 $14.4 Million - $21.1 Million
-855,700 Reduced 16.61%
4,297,000 $105 Million
Q1 2018

May 15, 2018

BUY
$16.68 - $22.07 $3.92 Million - $5.19 Million
235,000 Added 4.78%
5,152,700 $88.1 Million
Q4 2017

Feb 14, 2018

BUY
$11.23 - $19.1 $21.4 Million - $36.4 Million
1,906,700 Added 63.32%
4,917,700 $93.2 Million
Q3 2017

Nov 14, 2017

BUY
$15.41 - $32.17 $46.4 Million - $96.9 Million
3,011,000
3,011,000 $53 Million

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $19.4B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track D. E. Shaw & Co., Inc. Portfolio

Follow D. E. Shaw & Co., Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.